Entorhinal cortex astrocytic atrophy in human frontotemporal dementia

Area of Science:

• Neuroscience
• Neuropathology
• Astrocyte Biology

Background:

• The pathophysiology of Fronto Temporal Dementia (FTD) is not fully understood, with the specific role of astroglia being unclear.
• Research on astrocytic alterations in human dementia, particularly at the anatomical and morphometric level, is limited.

Purpose of the Study:

• To investigate the hypothesis that astrocytic alterations contribute to FTD pathophysiology.
• To explore the anatomical and morphometric characteristics of astrocytes in the human entorhinal cortex (EC) of FTD patients.

Main Methods:

• Conducted a tri-dimensional (3-D) anatomical and morphometric study.
• Analyzed glial fibrillary acidic protein (GFAP)-positive and glutamine synthetase (GS)-positive astrocytes in the human entorhinal cortex (EC).
• Compared FTD patient samples with non-dementia (ND) control samples.

Main Results:

• Observed significant astrocyte atrophy in GFAP-positive astrocytes in FTD patients compared to controls.
• Characterized this atrophy by a decrease in the area and volume of GFAP-positive and GFAP/GS co-expressing astrocytes.
• Found only minor changes in GS-positive astrocytes, suggesting specific astrocytic subtypes are affected.

Conclusions:

• Provides evidence for astrocyte atrophy and dysfunction in the human entorhinal cortex in FTD.
• Hypothesizes that FTD is a gliopathological disease, not solely neuropathological.
• Emphasizes the critical role of astrocytes in FTD pathological processes and disease development.